AstraZeneca is a global pharmaceutical company combining Swedish and British innovation.

 

We are delighted to welcome Mr Leon Wang, Executive Vice President International and CEO China of AstraZeneca, to this APAC webinar for SwedCham members only.

 

We will get the opportunity to hear about AstraZeneca's efforts to overcome the COVID-19 pandemic, its focus on harnessing the power of science, digital innovation and partnership to build more resilient healthcare systems post-pandemic, and their determination to make health happen for as many people, in as many countries as possible.

​

Moderator for this webinar is Mr. Peter Ling-Vannerus, Chief Representative of SEB Beijing.

 

AstraZeneca develops, manufactures and sells pharmaceuticals and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas. AstraZeneca has its corporate headquarters in Cambridge, United Kingdom, and its main research and development (R&D) centers are in Cambridge (UK), Gaithersburg (Maryland, US), Gothenburg (Sweden) and Warsaw (Poland)